Follow the 대웅제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 대웅제약 has published 47 insider filings. The latest transaction was reported on 7 July 2026 (Purchase). Among the most active insiders: 국민연금공단. All data is accessible without an account.
45
Insider Decl.
n/a
Thresholds
n/a
16 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.